Patient Demographics
Diabetes Status
Home Medications
Complications
RetinopathyNephropathyNeuropathyFoot Ulcers
ASCVD/CADStroke/TIAPADHeart Failure
Dosing Strategy
Use 0.3 for high risk/elderly. Higher for steroid use.
Generated Note
Thank you for your consultation. We were consulted regarding diabetes management during hospitalization for this — y/o male with T2DM. He seems to be unclear (based on available information). Assessment: • — y/o male, known T2DM. • Consulted for inpatient glycemic management during admission for: —. • Current inpatient glucose trend: —. • Chronic control appears: unclear. • Microvascular complications: None known. • Macrovascular complications: None known. Plan: 1) Diet/monitoring: • Diabetic diet if no contraindication. • Target inpatient BG for most patients: **140–180 mg/dL**. • Check BG AC & HS if eating; if NPO consider Q4–6H monitoring. 2) Medications: • Hold/avoid **oral/non-insulin agents during acute hospitalization** unless a specific indication and safety profile allow continuation (institution-dependent). • Home meds (documented): None documented • Home insulin (documented): None documented 3) Insulin regimen (draft; clinician to confirm): ⚠️ Weight not entered → cannot calculate weight-based insulin dose. 4) Labs / evaluation: • HbA1c: —%. • Consider urine ACR / proteinuria assessment if not previously documented (especially if nephropathy suspected). 5) Safety: • Hypoglycemia protocol: - Treat if BG <70 mg/dL (alert level); urgent if <54 mg/dL. - If able to take PO: give fast-acting carbohydrate, recheck in 15 min, repeat until ≥70. - If NPO/altered: IV dextrose per protocol; consider glucagon if no IV access. - Review insulin doses and contributing factors after any hypoglycemia episode. 6) CV risk / statin: • Lipid/ASCVD prevention (discharge planning): - If age 40–75 (most people with diabetes) → at least moderate-intensity statin unless contraindicated. - If ASCVD/high risk → high-intensity statin (as tolerated). 7) Follow-up: • Discharge / follow-up: - Ensure home regimen reconciliation + education. - Arrange follow-up with PHC / diabetes clinic within 2–4 weeks (earlier if insulin started/changed). - Screen/monitor complications (albuminuria, eye exam history, foot care). References (ADA): • Inpatient BG target 140–180 mg/dL for most hospitalized patients. • Hypoglycemia definitions/levels (<70; <54). • Statin recommendations in ADA Standards (CVD & risk management).
Disclaimer: This tool is for educational/drafting purposes only. Clinician must verify all doses and plans.